Overview
GE2270A is a thiopeptide antibiotic produced by Planobispora rosea that inhibits bacterial translation by targeting elongation factor Tu (EF-Tu). It represents a structurally distinct class of antimicrobial peptides with a unique bacterial ribosome mechanism. While its poor aqueous solubility has historically limited development, GE2270A and related thiopeptides serve as important pharmacological tools for studying bacterial protein synthesis and as templates for next-generation antibiotics targeting the EF-Tu pathway.
Mechanism of Action
GE2270A binds with high affinity to the GTP-binding domain of bacterial elongation factor Tu (EF-Tu), preventing it from delivering aminoacyl-tRNAs to the ribosomal A-site. Without functional EF-Tu, bacterial ribosomes cannot elongate polypeptide chains, halting protein synthesis. This mechanism is entirely distinct from beta-lactam, aminoglycoside, and fluoroquinolone antibiotics, making GE2270A active against many multi-drug resistant strains. Mammalian EF-1α has different structural features, conferring selectivity.
Potential Benefits
- Activity against gram-positive multi-drug resistant pathogens
- Unique EF-Tu mechanism avoids cross-resistance with conventional antibiotics
- Research tool for studying bacterial translation
- Template for novel antibiotic development
Research Dosage Notes
The following reflects doses used in published research studies. This is not medical advice.
Research use only. No established therapeutic dosing.
Amino Acid Sequence
Complex thiopeptide macrocycle (not standard linear peptide)
Side Effects & Safety
- Poor systemic bioavailability limits toxicity assessment
- Potential GI effects
Synergistic Compounds
The following compounds have been studied alongside GE2270A for potential complementary or synergistic effects:
Learn More
References & Further Reading
- [object Object]